Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis. (6th May 2020) - Wang, A.; Hornick, N.; Lim, Y.; Gehlhausen, J.; Siegel, J.; Wang, J.; Foss, F.; Lim, I.; Zubek, A.; Milstone, L.; Galan, A.; King, B.; et al.